302440 logo

SK Bioscience Co Ltd (302440)

SK bioscience Co.,Ltd. engages in the research and development, production, and distribution of vaccines and biopharmaceuticals in Korea and internationally. Its product portfolio includes Skycellflu, a cell cultured influenza surface antigen vaccine; Skycellflu 4-ga pre-filled syringe; pneumococcal vaccine for adult and infant; Skyzoster, a shingles virus v...

KOHealthcareBiotechnologyKorea

公司簡介

股票程式碼
302440
ISIN程式碼
KR7302440003
貨幣
Korean Won (KRW)

聯絡資訊

公司地址
310, Pangyo-ro, Seongnam-si, South Korea, 13494
聯絡電話
82 2 2008 2200
公司網站
https://www.skbioscience.co.kr
財年結束
December

財務亮點

市值
$999,999.99
毛利潤(TTM)
$999,999.99
資產回報率(TTM)
-3.24%
EBITDA
$-999,999.99
收入(TTM)
$999,999.99